The Scientific Research and Development team at ANGLE spearheads the advancement of liquid biopsy technologies, focusing on the innovation and enhancement of Parsortix® for capturing circulating tumor cells. This multidisciplinary team, comprised of scientists and clinical laboratory experts, conducts research, develops assays, and ensures high-quality manufacturing processes to drive breakthroughs in cancer diagnostics and improve patient outcomes. Their collaborative efforts support both product development and clinical applications, contributing to ANGLE's position as a leader in the field.
Adrian Newland
Scientific Advisor
Anne-Sophie Pailhes-...
R&D Director
Ashok Venkitaraman
Scientific Advisor
Clive Stanway
Scientific Advisor
Daniel Danila
Scientific Advisor
Greg Shaw
Scientific Advisor
Harold Swerdlow
Scientific Advisor
James Reuben
Scientific Advisor
Joseph Khoury
Scientific Advisor
Stefan Peter
Senior Group Leader, Product &...